Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,289 | 58,152 | 141,680 | 136,287 | 74,933 |
| Marketable Securities | 82,999 | 90,683 | 20,052 | 40,214 | 55,473 |
| TOTAL | $135,096 | $151,527 | $164,267 | $179,877 | $133,132 |
| Non-Current Assets | |||||
| PPE Net | 7,744 | 8,312 | 8,594 | 9,070 | 9,529 |
| Other Non-Current Assets | 1,780 | 1,780 | 1,780 | 1,780 | 1,780 |
| TOTAL | $9,524 | $10,092 | $10,374 | $10,850 | $11,309 |
| Total Assets | $144,620 | $161,619 | $174,641 | $190,727 | $144,441 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,114 | 3,760 | 2,389 | 2,650 | 3,947 |
| Accrued Expenses | 7,092 | 7,670 | 7,475 | 7,719 | 8,756 |
| TOTAL | $9,206 | $11,430 | $9,864 | $10,369 | $12,703 |
| Non-Current Liabilities | |||||
| TOTAL | $6,355 | $6,283 | $6,211 | $6,444 | $6,337 |
| Total Liabilities | $15,561 | $17,713 | $16,075 | $16,813 | $19,040 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,038 | 3,035 | 3,019 | 3,016 | 2,468 |
| Common Shares | 49 | 49 | 48 | 48 | 39 |
| Retained earnings | -271,920 | -254,431 | -236,263 | -218,585 | -199,506 |
| Other shareholders' equity | 9 | -23 | 39 | 153 | 363 |
| TOTAL | $129,059 | $143,906 | $158,566 | $173,914 | $125,401 |
| Total Liabilities And Equity | $144,620 | $161,619 | $174,641 | $190,727 | $144,441 |